OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies
Hailong Tian, Tingting Zhang, Siyuan Qin, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 243

Showing 1-25 of 243 citing articles:

Oral squamous cell carcinomas: state of the field and emerging directions
Yunhan Tan, Zhihan Wang, Mengtong Xu, et al.
International Journal of Oral Science (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 259

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106

Drug-induced oxidative stress in cancer treatments: Angel or devil?
Hao Jiang, Jing Zuo, Bowen Li, et al.
Redox Biology (2023) Vol. 63, pp. 102754-102754
Open Access | Times Cited: 100

Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies
Yi Zhang, Qiong Li, Zhao Huang, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4568-4568
Open Access | Times Cited: 82

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 81

Cuproptosis: Harnessing Transition Metal for Cancer Therapy
Wuyin Wang, Wentao Mo, Zishan Hang, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19581-19599
Closed Access | Times Cited: 80

Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Haowei Sun, Yingmei Li, Peng Zhang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 70

Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
Alshayma N. Al-Thani, Asma Ghafoor Jan, Mohamed Abbas, et al.
Life Sciences (2024) Vol. 352, pp. 122899-122899
Open Access | Times Cited: 62

Simulation-based approaches for drug delivery systems: Navigating advancements, opportunities, and challenges
Iman Salahshoori, Mahdi Golriz, Marcos A.L. Nobre, et al.
Journal of Molecular Liquids (2023) Vol. 395, pp. 123888-123888
Open Access | Times Cited: 52

Biomaterials for Drug Delivery and Human Applications
Paolo Trucillo
Materials (2024) Vol. 17, Iss. 2, pp. 456-456
Open Access | Times Cited: 52

Molecularly imprinted polymers (MIPs): emerging biomaterials for cancer theragnostic applications
Min Seok Kang, Euni Cho, Hye Eun Choi, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 47

Recent nanotheranostic approaches in cancer research
Deepshikha Gupta, Priyanka Roy, Rishabh Sharma, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 43

Aptamers as an approach to targeted cancer therapy
Fatemeh Mahmoudian, Azin Ahmari, Shiva Shabani, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 33

Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies
Behnam Najafiyan, Zahra Bokaii Hosseini, Samar Esmaelian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116207-116207
Open Access | Times Cited: 24

Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent
Muhammad Ali, Viviana Benfante, Domenico Di Raimondo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 126-126
Open Access | Times Cited: 21

Advances in inorganic nanoparticles-based drug delivery in targeted breast cancer theranostics
Vahid Rahimkhoei, Asaad H. Alzaidy, May Jaleel Abed, et al.
Advances in Colloid and Interface Science (2024) Vol. 329, pp. 103204-103204
Closed Access | Times Cited: 21

Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis
Mohsen Ahmadi, Christoph A. Ritter, Thomas von Woedtke, et al.
Chemical Science (2024) Vol. 15, Iss. 6, pp. 1966-2006
Open Access | Times Cited: 20

Emerging Applications of Nanoparticles in the Diagnosis and Treatment of Breast Cancer
Josephine B. Oehler, Weranga Rajapaksha, Hugo Albrecht
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 723-723
Open Access | Times Cited: 18

A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer
Sudharshan Reddy Dachani, Mohammed Kaleem, Md Ali Mujtaba, et al.
ACS Omega (2024) Vol. 9, Iss. 9, pp. 10030-10048
Open Access | Times Cited: 17

Dual targeting of FR+CD44 overexpressing tumors by self-assembled nanoparticles quantitatively conjugating folic acid-hyaluronic acid to the GSH-sensitively modified podophyllotoxin
Chaozheng Zhang, Yao Chen, Yi Y. Zuo, et al.
Chemical Engineering Journal (2025), pp. 159276-159276
Closed Access | Times Cited: 3

Brain‐Targeted HFn‐Cu‐REGO Nanoplatform for Site‐Specific Delivery and Manipulation of Autophagy and Cuproptosis in Glioblastoma
Wenhui Jia, Hailong Tian, Jingwen Jiang, et al.
Small (2022) Vol. 19, Iss. 2
Closed Access | Times Cited: 68

Nanotechnology-empowered strategies in treatment of skin cancer
Jyoti Chandra, Nazeer Hasan, Nazim Nasir, et al.
Environmental Research (2023) Vol. 235, pp. 116649-116649
Closed Access | Times Cited: 41

Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer
Xingyu Chen, Lixiang Feng, Yujing Huang, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 104-104
Open Access | Times Cited: 38

Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery
Xiaohui Wang, Hong Zhang, Xiaohong Chen, et al.
Acta Biomaterialia (2023) Vol. 166, pp. 42-68
Closed Access | Times Cited: 37

Exploring Nanocarriers as Treatment Modalities for Skin Cancer
Mohammad Adnan, Md Habban Akhter, Obaid Afzal, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5905-5905
Open Access | Times Cited: 28

Page 1 - Next Page

Scroll to top